Evidence map›Paper›PMID 24748782›Full record

ReviewClinical interventions in aging2014

Oxidative stress and its downstream signaling in aging eyes.

María Dolores Pinazo-Durán, Roberto Gallego-Pinazo, Jose Javier García-Medina, Vicente Zanón-Moreno, Carlo Nucci, Rosa Dolz-Marco, Sebastián Martínez-Castillo, Carmen Galbis-Estrada, Carla Marco-Ramírez, Maria Isabel López-Gálvez and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Clinical interventions in aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 123 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. International journal of molecular sciences · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Potential New Target for Dry Eye Disease-Oxidative Stress.Antioxidants (Basel, Switzerland) · 2024
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Mitochondrial dysfunction in glaucomatous degeneration.International journal of ophthalmology · 2023
    Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

María Dolores Pinazo-DuránOphthalmic Research Unit "Santiago Grisolía", Valencia, Spain.
Roberto Gallego-PinazoDepartment of Ophthalmology, Macula Section, The University and Polytechnic Hospital La Fe, Valencia, Spain.
Jose Javier García-MedinaOphthalmic Research Unit "Santiago Grisolía", Valencia, Spain ; Department of Ophthalmology, University Hospital Reina Sofia, Murcia, Spain.
Vicente Zanón-MorenoOphthalmic Research Unit "Santiago Grisolía", Valencia, Spain ; Faculty of Medicine, University of Valencia, Spain.
Carlo NucciUniversity of Rome Tor Vergata, Rome, Italy.
Rosa Dolz-MarcoDepartment of Ophthalmology, Macula Section, The University and Polytechnic Hospital La Fe, Valencia, Spain.
Sebastián Martínez-CastilloDepartment of Ophthalmology, Macula Section, The University and Polytechnic Hospital La Fe, Valencia, Spain.
Carmen Galbis-EstradaOphthalmic Research Unit "Santiago Grisolía", Valencia, Spain.
Carla Marco-RamírezOphthalmic Research Unit "Santiago Grisolía", Valencia, Spain.
Maria Isabel López-GálvezInstituto de Oftalmobiología Aplicada (IOBA), Valladolid, Spain.
David J GalarretaInstituto de Oftalmobiología Aplicada (IOBA), Valladolid, Spain.
Manuel Díaz-LlópisFaculty of Medicine, University of Valencia, Spain.
Hospital Universitari i Politècnic La Fe · ESUniversitat de València · ESHospital Reina Sofía de Murcia · ESUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOxidative stress (OS) and its biomarkers are the biochemical end point of the imbalance between reactive oxygen species (ROS) production and the ability of the antioxidant (AOX) biological systems to fight against oxidative injury.

objectiveWe reviewed the role of OS and its downstream signaling in aging eyes.

methodsA search of the literature and current knowledge on the physiological and pathological mechanisms of OS were revisited in relation to the eyes and the aging process. Most prevalent ocular diseases have been analyzed herein in relation to OS and nutraceutic supplements, such as dry-eye disorders, glaucoma, age-related macular degeneration, and diabetic retinopathy.

resultsClinical, biochemical, and molecular data from anterior and posterior eye segment diseases point to OS as the common pathogenic mechanism in the majority of these ocular disorders, many of which are pathologies causing visual impairment, blindness, and subsequent loss of life quality. Studies with nutraceutic supplements in aging eye-related pathologies have also been reviewed.

conclusionOS, nutritional status, and nutraceutic supplements have to be considered within the standards of care of older ophthalmologic patients. OS biomarkers and surrogate end points may help in managing the aging population with ocular diseases.

Indexed as

AgedAgingDietary SupplementsDry Eye SyndromesEyeGlaucomaHumansOcular Physiological PhenomenaOxidative StressRetinal Diseasesagingantioxidantsepidemiologyeyesophthalmic diseasesoxidative stress

Identifiers

PMID24748782
PMCPMC3990383
OpenAlexW2158851133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.